The Daily Hit is a recap of the top financial news stories for Oct. 25, 2023. On the Site New Mexico Pursues Unpaid Taxes From Cannabis...
A federal appeals court panel has begun hearing arguments in a case involving a Seattle doctor who sued the U.S. Drug Enforcement Administration for...
– European patent provides composition of matter and medical use protection for the Company’s proprietary deuterated psilocybin analog and deuterated...
Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) announced that the United States Patent and Trademark Office has issued two patent grants that offer protection...
Cybin has added to this growing IP portfolio with the granting of two more patents for its DMT program. The post Cybin Granted Two New Patents...
–New United States patent grants offer protection for deuterated analogs of DMT including composition of matter, medical use and synthesis – – Intellectual...
Merck has ended work on two separate Phase II studies of its small molecule for treatment-resistant depression and mild-to-moderate Alzheimer’s disease,...
This past quarter has been, without a doubt, the busiest and most transformative three months of this year— perhaps even of the entire history of the...
Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine news to help you catch up and stay informed. The post News...
Psychedelics companies Cybin Inc. (NYSE: CYBN) and Small Pharma Inc. (OTCQB: DMTTF) have completed their August acquisition agreement. Following their...